+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Transcatheter implantation of aortic valve prostheses into degenerated mitral valve bioprostheses and failed annuloplasty rings: outcomes according to access route and Mitral Valve Academic Research Consortium (MVARC) criteria



Transcatheter implantation of aortic valve prostheses into degenerated mitral valve bioprostheses and failed annuloplasty rings: outcomes according to access route and Mitral Valve Academic Research Consortium (MVARC) criteria



Eurointervention 12(12): 1520-1526



The study sought to assess outcomes of transcatheter mitral valve-in-valve implantation (TMVIV) for degenerated bioprostheses and transcatheter mitral valve-in-ring implantation (TMVIR) for failed annuloplasty rings according to access route and the Mitral Valve Academic Research Consortium (MVARC) criteria. Twenty-four patients (72±13 years; eight men [33%]) underwent TMVIV (n=14) or TMVIR (n=10) for mitral regurgitation (MR; n=17) or stenosis (n=7) using balloon-expandable bioprostheses. Transapical (TA) access was chosen in 13, and transseptal (TS) access in 11 patients. MVARC technical success, device success and procedural success were 95.8%, 41.7% and 33.3%, respectively, with no differences between access routes. Cardiac output (CO) increased significantly by 1.1±0.8 l/min in TS patients, but not in TA patients (ΔCO=0.0±0.5 l/min; p=0.0051). Overall three-year survival was estimated at 57.6% (95% confidence interval: 33.9-81.3; TA 35.5% [5.2-65.9]; TS 90.9% [73.9-100]). Survival up to four years according to vascular access showed a clear benefit in patients treated transseptally (p=0.045). Regardless of the access route, TMVIV/TMVIR was associated with high technical success yet impaired device success. In the long term, TA access had a significant adverse impact on survival.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 060414600

Download citation: RISBibTeXText

PMID: 27998844


Related references

Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. European Heart Journal 40(5): 441-451, 2019

Transcatheter mitral valve implantation for degenerated mitral bioprostheses or failed surgical annuloplasty rings: A systematic review and meta-analysis. Journal of Cardiac Surgery 33(9): 508-519, 2018

Double transcatheter valve-in-valve implantation for degenerated aortic and mitral bioprostheses. Revista Portuguesa de Cirurgia Cardio-Toracica e Vascular 20(3): 131-134, 2015

Simultaneous transcatheter aortic and mitral valve-in-valve implantation in a patient with degenerated bioprostheses and high surgical risk. Thoracic and Cardiovascular Surgeon 59(8): 490-492, 2012

Percutaneous Mitral Valve Repair With the MitraClip in Primary Compared With Secondary Mitral Valve Regurgitation Using the Mitral Valve Academic Research Consortium Criteria. Journal of Invasive Cardiology 29(4): 145-150, 2017

Combined Transapical Valve-in-Valve/Valve-in-Ring Transcatheter Mitral Valve Implantation and Paravalvular Leak Closure for Failed Mitral Valve Surgery. Canadian Journal of Cardiology 34(8): 1088.E3-1088.E6, 2018

Transapical transcatheter mitral valve-in-valve implantation versus minimally invasive surgery for failed mitral bioprostheses. Interactive Cardiovascular and Thoracic Surgery 25(1): 57-61, 2017

Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings. Journal of the American College of Cardiology 70(9): 1121-1131, 2017

Transcatheter mitral valve-in-valve implantation in patients with degenerated bioprostheses. Jacc. Cardiovascular Interventions 5(3): 341-349, 2012

A staged approach to transcatheter aortic valve implantation and mitral valve-in-valve implantation for a degenerated bioprosthesis in a high-risk patient. Interactive Cardiovascular and Thoracic Surgery 15(4): 764-765, 2012

Comparative performance of transcatheter aortic valve-in-valve implantation versus conventional surgical redo aortic valve replacement in patients with degenerated aortic valve bioprostheses: systematic review and meta-analysis. European Journal of Cardio-Thoracic Surgery 53(3): 495-504, 2018

First-in-man implantation of a trans-catheter aortic valve in a mitral annuloplasty ring: novel treatment modality for failed mitral valve repair. European Journal of Cardio-Thoracic Surgery 39(6): 1054-1056, 2011

Transcatheter Edwards Sapien XT valve in valve implantation in degenerated aortic bioprostheses via transfemoral access. Clinical Research in Cardiology 101(12): 993, 2012

Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral position. Catheterization and Cardiovascular Interventions 76(4): 608-615, 2010

Reoperative "valve-in-valve" transapical transcatheter mitral valve replacement in a high-risk patient with a recent transapical transcatheter aortic valve replacement and a degenerated bioprosthetic mitral valve. Journal of Thoracic and Cardiovascular Surgery 148(5): E209-E210, 2014